Vitamin D insufficiency in myeloproliferative neoplasms and myelodysplastic syndromes: Clinical correlates and prognostic studies

American Journal of Hematology

Volumn 86, Issue 12, 2011, Pages 1013-1016

  Pardanani, Animesh ^a   Drake, Matthew T ^a   Finke, Christy ^a   Lasho, Terra L ^a   Rozell, Shaina A ^a   Jimma, Thitina ^a   Tefferi, Ayalew ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VITAMIN D;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DISEASE FREE SURVIVAL; DISEASE SEVERITY; FEMALE; HUMAN; LEUKEMIA; LIQUID CHROMATOGRAPHY; MAJOR CLINICAL STUDY; MALE; MYELODYSPLASTIC SYNDROME; MYELOID METAPLASIA; POLYCYTHEMIA VERA; PRIORITY JOURNAL; PROGNOSIS; TANDEM MASS SPECTROMETRY; THROMBOCYTHEMIA; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY;

25-HYDROXYVITAMIN D 2; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CALCIFEDIOL; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; MYELODYSPLASTIC SYNDROMES; MYELOPROLIFERATIVE DISORDERS; PREVALENCE; PROGNOSIS; SEVERITY OF ILLNESS INDEX; SURVIVAL ANALYSIS; UNITED STATES; VITAMIN D DEFICIENCY; YOUNG ADULT;

EID: 81355161072     PISSN: 03618609     EISSN: 10968652     Source Type: Journal    
DOI: 10.1002/ajh.22181     Document Type: Article

References (27)

1. Thacher TD, Clarke BL. Vitamin D insufficiency. Mayo Clin Proc 2011; 86: 50-60.
2. Batchelor AJ, Watson G, Compston JE. Changes in plasma half-life and clearance of 3H-25-hydroxyvitamin D3 in patients with intestinal malabsorption. Gut 1982; 23: 1068-1071.
3. Yin L, Grandi N, Raum E, et al. Meta-analysis: Longitudinal studies of serum vitamin D and colorectal cancer risk. Aliment Pharmacol Ther 2009; 30: 113-125.
4. Chen P, Hu P, Xie D, et al. Meta-analysis of vitamin D, calcium and the prevention of breast cancer. Breast Cancer Res Treat 2010; 121: 469-477.
5. Gandini S, Boniol M, Haukka J, et al. Meta-analysis of observational studies of serum 25-hydroxyvitamin D levels and colorectal, breast and prostate cancer and colorectal adenoma. Int J Cancer 2011; 128: 1414-1424.
6. Helzlsouer KJ. Overview of the cohort consortium vitamin d pooling project of rarer cancers. Am J Epidemiol 2010; 172: 4-9.
7. Wactawski-Wende J, Kotchen JM, Anderson GL, et al. Calcium plus vitamin D supplementation and the risk of colorectal cancer. N Engl J Med 2006; 354: 684-696.
8. Drake MT, Maurer MJ, Link BK, et al. Vitamin D insufficiency and prognosis in non-Hodgkin's lymphoma. J Clin Oncol 2010; 28: 4191-4198.
9. Shanafelt TD, Drake MT, Maurer MJ, et al. Vitamin D insufficiency and prognosis in chronic lymphocytic leukemia. Blood 2011; 117: 1492-1498.
10. Ng AC, Kumar SK, Rajkumar SV, et al. Impact of vitamin D deficiency on the clinical presentation and prognosis of patients with newly diagnosed multiple myeloma. Am J Hematol 2009; 84: 397-400.
11. Holick MF. Multiple myeloma and cancer: Is there a D-lightful connection? Am J Hematol 2009; 84: 393-394.
12. Claster S, Wood JC, Noetzli L, et al. Nutritional deficiencies in iron overloaded patients with hemoglobinopathies. Am J Hematol 2009; 84: 344-348.
13. Vardiman JW, Thiele J, Arber DA, et al. The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: Rationale and important changes. Blood 2009; 114: 937-951.
14. Gangat N, Caramazza D, Vaidya R, et al. DIPSS plus: A refined Dynamic International Prognostic Scoring System for primary myelofibrosis that incorporates prognostic information from karyotype, platelet count, and transfusion status. J Clin Oncol 2011; 29: 392-397.
15. Passamonti F, Cervantes F, Vannucchi AM, et al. A dynamic prognostic model to predict survival in primary myelofibrosis: A study by the IWG-MRT (International Working Group for Myeloproliferative Neoplasms Research and Treatment). Blood 2010; 115: 1703-1708.
16. Greenberg P, Cox C, LeBeau MM, et al. International scoring system for evaluating prognosis in myelodysplastic syndromes. Blood 1997; 89: 2079-2088.
17. Thomas MK, Lloyd-Jones DM, Thadhani RI, et al. Hypovitaminosis D in medical inpatients. N Engl J Med 1998; 338: 777-783.
18. McCarthy DM, Hibbin JA, Goldman JM. A role for 1, 25-dihydroxyvitamin D3 in control of bone-marrow collagen deposition? Lancet 1984; 1: 78-80.
19. Arlet P, Nicodeme R, Adoue D, et al. Clinical evidence for 1, 25-dihydroxycholecalciferol action in myelofibrosis. Lancet 1984; 1: 1013-1014.
20. Wieslander SB, Mortensen BT, Binderup L, et al. 1 alpha(OH)D3 (ETALPHA) treatment and receptor studies in 16 patients with chronic and myeloproliferative disorders. Eur J Haematol 1987; 39: 35-38.
21. Tsatalas C, Curtoglou G, Fotopoulos D, et al. 1 alpha(OH)D3 treatment and procollagen III (PC III) studies in idiopathic myelofibrosis. Haematologica 1989; 74: 559-562.
22. Foa P, Maiolo AT, Cortellaro M, et al. 1, 25-Dihydroxyvitamin D3 in the treatment of idiopathic thrombocythemia and myelofibrosis. Haematologica 1990; 75: 294-295.
23. Miyaura C, Abe E, Kuribayashi T, et al. 1 alpha, 25-Dihydroxyvitamin D3 induces differentiation of human myeloid leukemia cells. Biochem Biophys Res Commun 1981; 102: 937-943.
24. Mangelsdorf DJ, Koeffler HP, Donaldson CA, et al. 1, 25-Dihydroxyvitamin D3-induced differentiation in a human promyelocytic leukemia cell line (HL-60): Receptor-mediated maturation to macrophage-like cells. J Cell Biol 1984; 98: 391-398.
25. Brown G, Choudhry MA, Durham J, et al. Monocytically differentiating HL60 cells proliferate rapidly before they mature. Exp Cell Res 1999; 253: 511-518.
26. Hughes PJ, Marcinkowska E, Gocek E, et al. Vitamin D3-driven signals for myeloid cell differentiation-Implications for differentiation therapy. Leuk Res 2010; 34: 553-565.
27. Okamoto R, Akagi T, Koeffler P. Vitamin D compounds and myelodysplastic syndrome. Leuk Lymphoma 2008; 49: 12-13.